Detalhe da pesquisa
1.
cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation.
Cell Commun Signal
; 22(1): 22, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195584
2.
[Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
Zhongguo Zhong Yao Za Zhi
; 49(3): 842-848, 2024 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-38621888
3.
Chelerythrine chloride inhibits the progression of colorectal cancer by targeting cancer-associated fibroblasts through intervention with WNT10B/ß-catenin and TGFß2/Smad2/3 axis.
Phytother Res
; 37(10): 4674-4689, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402476
4.
Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy.
Phytother Res
; 37(5): 2036-2050, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748953
5.
[Thoughts of treatment of tumor diseases based on toxic pathogen theory].
Zhongguo Zhong Yao Za Zhi
; 48(5): 1413-1419, 2023 Mar.
Artigo
em Zh
| MEDLINE | ID: mdl-37005825
6.
[Technical points of human use experience of ethnic medicine].
Zhongguo Zhong Yao Za Zhi
; 48(5): 1402-1406, 2023 Mar.
Artigo
em Zh
| MEDLINE | ID: mdl-37005823
7.
[CiteSpace knowledge map of research hotspots and frontiers of Polygalae Radix].
Zhongguo Zhong Yao Za Zhi
; 48(6): 1664-1672, 2023 Mar.
Artigo
em Zh
| MEDLINE | ID: mdl-37005854
8.
[Guideline for clinical comprehensive evaluation of Chinese patent medicine (2022 version)].
Zhongguo Zhong Yao Za Zhi
; 48(1): 256-264, 2023 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-36725278
9.
Opportunities and hurdles to European market access for multi-herbal traditional Chinese medicine products: An analysis of EU regulations for combination herbal medicinal products.
Pharmacol Res
; 186: 106528, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332812
10.
Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects.
Pharmacol Res
; 184: 106440, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108874
11.
Pull the plug: Anti-angiogenesis potential of natural products in gastrointestinal cancer therapy.
Phytother Res
; 36(9): 3371-3393, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35871532
12.
Preclinical evidence for quercetin against inflammatory bowel disease: a meta-analysis and systematic review.
Inflammopharmacology
; 30(6): 2035-2050, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227442
13.
[Clinical comprehensive evaluation of Chinese patent medicine based on EVIDEM].
Zhongguo Zhong Yao Za Zhi
; 47(10): 2833-2840, 2022 May.
Artigo
em Zh
| MEDLINE | ID: mdl-35718504
14.
[Category of Chinese medicine registration:historical evolution,current status,and problems].
Zhongguo Zhong Yao Za Zhi
; 47(2): 562-568, 2022 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-35179001
15.
[Expert consensus on human use experience research of traditional Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 47(18): 4829-4834, 2022 Sep.
Artigo
em Zh
| MEDLINE | ID: mdl-36164892
16.
[Relevant thoughts on development of traditional Chinese medicine industry in new era].
Zhongguo Zhong Yao Za Zhi
; 47(17): 4799-4813, 2022 Sep.
Artigo
em Zh
| MEDLINE | ID: mdl-36164887
17.
[Reflections on supervision strategies of new Tibetan drug registration].
Zhongguo Zhong Yao Za Zhi
; 47(19): 5383-5388, 2022 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-36472046
18.
[Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].
Zhongguo Zhong Yao Za Zhi
; 47(4): 1120-1125, 2022 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-35285213
19.
[Research and development strategies of new Chinese medicines based on new regulations].
Zhongguo Zhong Yao Za Zhi
; 46(12): 3150-3155, 2021 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-34467707
20.
[Data collection, quality and evidence formation for human use experience of traditional Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 46(7): 1681-1685, 2021 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-33982468